<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Stanford GE</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Yoga is an emerging exercise choice for people with cystic fibrosis (CF), but evidence of its effect in this population is scarce, with a recent systematic review advocating for further research. &lt;u>Y&lt;/u>oga &lt;u>O&lt;/u>utcomes &lt;u>G&lt;/u>et &lt;u>A&lt;/u>ssessed in &lt;u>CF&lt;/u> (YOGA-CF) is a real-world multicentre randomised controlled trial (RCT) investigating a bespoke CF-specific online 12-week yoga intervention, vers usual care, to determine effectiveness for adults with CF.&lt;h4>Methods and analysis&lt;/h4>A multicentre RCT of adults with CF across the UK. Participants are randomised to usual care or a 12-week online bespoke yoga programme with an expectation of two classes completed weekly. Assessments of lung function, 1 min sit-to-stand, the Cystic Fibrosis Questionnaire-Revised </pubmed_abstract><journal>BMJ open respiratory research</journal><pagination>e003405</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12778263</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&amp;lt;u&amp;gt;Y&amp;lt;/u&amp;gt;oga &amp;lt;u&amp;gt;O&amp;lt;/u&amp;gt;utcomes &amp;lt;u&amp;gt;G&amp;lt;/u&amp;gt;et &amp;lt;u&amp;gt;A&amp;lt;/u&amp;gt;ssessed in &amp;lt;u&amp;gt;C&amp;lt;/u&amp;gt;ystic &amp;lt;u&amp;gt;F&amp;lt;/u&amp;gt;ibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial-investigating effects of a 12-week yoga intervention for adults with cystic fibrosis.</pubmed_title><pmcid>PMC12778263</pmcid><pubmed_authors>Stanford GE</pubmed_authors><pubmed_authors>Cameron RA</pubmed_authors><pubmed_authors>Scarborough P</pubmed_authors><pubmed_authors>Charman SC</pubmed_authors><pubmed_authors>Wagner AP</pubmed_authors><pubmed_authors>Simmonds NJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>&amp;lt;u&amp;gt;Y&amp;lt;/u&amp;gt;oga &amp;lt;u&amp;gt;O&amp;lt;/u&amp;gt;utcomes &amp;lt;u&amp;gt;G&amp;lt;/u&amp;gt;et &amp;lt;u&amp;gt;A&amp;lt;/u&amp;gt;ssessed in &amp;lt;u&amp;gt;C&amp;lt;/u&amp;gt;ystic &amp;lt;u&amp;gt;F&amp;lt;/u&amp;gt;ibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial-investigating effects of a 12-week yoga intervention for adults with cystic fibrosis.</name><description>&lt;h4>Introduction&lt;/h4>Yoga is an emerging exercise choice for people with cystic fibrosis (CF), but evidence of its effect in this population is scarce, with a recent systematic review advocating for further research. &lt;u>Y&lt;/u>oga &lt;u>O&lt;/u>utcomes &lt;u>G&lt;/u>et &lt;u>A&lt;/u>ssessed in &lt;u>CF&lt;/u> (YOGA-CF) is a real-world multicentre randomised controlled trial (RCT) investigating a bespoke CF-specific online 12-week yoga intervention, vers usual care, to determine effectiveness for adults with CF.&lt;h4>Methods and analysis&lt;/h4>A multicentre RCT of adults with CF across the UK. Participants are randomised to usual care or a 12-week online bespoke yoga programme with an expectation of two classes completed weekly. Assessments of lung function, 1 min sit-to-stand, the Cystic Fibrosis Questionnaire-Revised </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T12:35:52.83Z</modification><creation>2026-05-30T03:11:11.676Z</creation></dates><accession>S-EPMC12778263</accession><cross_references><pubmed>41494700</pubmed><doi>10.1136/bmjresp-2025-003405</doi></cross_references></HashMap>